Incyte Corporation - Common Stock (INCY) Covered Calls

Incyte Corporation - Common Stock covered calls Incyte Corporation is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

You can sell covered calls on Incyte Corporation - Common Stock to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for INCY (prices last updated Fri 4:16 PM ET):

Incyte Corporation - Common Stock (INCY) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
77.20 -0.44 69.34 82.00 865K 66 17B
Covered Calls For Incyte Corporation - Common Stock (INCY)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jun 21 77.5 3.00 79.00 -1.9% -19.3%
Sep 20 77.5 6.10 75.90 2.1% 6.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Incyte Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of proprietary small molecule drugs to treat serious unmet medical needs. The company's product, Jakafi (ruxolitinib), a JAK1 and JAK2 inhibitor, is currently approved in the U.S. for the treatment of intermediate or high-risk myelofibrosis and is in development as a potential treatment for other cancers. Incyte was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.